Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
By Elana Gotkine HealthDay Reporter
FRIDAY, July 11, 2025 -- The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those without health insurance, according to a study published online July 7 in JAMA Network Open.
Jingxuan Zhao, Ph.D., M.P.H., from the American Cancer Society in Atlanta, and colleagues conducted a cross-sectional study involving adults who received a new diagnosis of stage IV melanoma (12,048), non-small cell lung cancer (NSCLC; 152,610), or renal cell carcinoma (18,782) who were identified before and after U.S. Food and Drug Administration approval of ICIs. A six-group propensity score-weighting difference-in-differences (DID) approach was applied to examine changes in survival before and after ICI approval among individuals without insurance or with Medicaid versus those with private insurance for each type of cancer.
The researchers found that for those with a diagnosis of melanoma, two-year overall survival rates increased post-ICI approval among uninsured individuals (16.2 to 28.3 percent) and those with private insurance (28.7 to 46.0 percent), resulting in a widening disparity of 6.1 percentage points after adjustment for sociodemographic characteristics. The survival disparity between people without insurance and those with private insurance widened to 1.3 percentage points among people with a diagnosis of NSCLC. No significant changes were seen in survival differences between people with Medicaid and those with private insurance with the introduction of ICIs.
"Expanding Medicaid to individuals without health insurance coverage may improve their access to effective cancer treatments that are also costly, such as ICIs," Zhao said in a statement.
One author disclosed ties to Pfizer and PRIME Education.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Racialized Economic Segregation Linked to Advanced Cancer Diagnosis
FRIDAY, Aug. 1, 2025 -- People living in racially and economically segregated neighborhoods are more likely to be diagnosed with advanced-stage breast and cervical cancer...
Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer
FRIDAY, Aug. 1, 2025 -- Occupation as a firefighter is associated with elevated cancer mortality, especially for skin and kidney cancer, according to a study published online July...
Increased Intake of Ultraprocessed Food Raises Lung Cancer Risk
THURSDAY, July 31, 2025 -- Higher consumption of ultraprocessed foods (UPF) is associated with increased risk of lung cancer, according to a study published online July 29 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.